Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-0948-2026

DSAART LLC recalls Brand Name: AART Pectoral Implant Product Name: Pectoral Implant Model/Catalog Number…

DSAART LLCCarson City, NV, United StatesReported Dec 24, 2025 · 6 months ago
Legal News Analyst ·

Reason for recall

Due to manufactured products that deviated from established specifications and being distributed without obtaining the required FDA premarket approvals or clearances.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Brand Name: AART Pectoral Implant Product Name: Pectoral Implant Model/Catalog Number: 500-106-5 Pectoral Implant style 1 size 6 left UDI-DI code: B4905001065 500-106-6 Pectoral Implant style 1 size 6 right UDI-DI code: B4905001066 500-200-5 Pectoral Implant style 2 size 0 left UDI-DI code: B4950020205 500-200-6 500-201-5 500-201-6 500-202-5 500-202-6 500-403-5500-403-6
    UDI-DI codeCatalog # Number
    35 affected lots
    24-03-002500-106-6B490500106624-03-003500-200-5B490500200524-12-00425-02-002
    +27 more500-200-6B490500200624-12-00525-02-003500-201-5B490500201524-11-01525-02-00425-05-002500-201-6B490500201624-12-01725-02-005500-202-5B490500202524-12-01825-03-018500-202-6B490500202624-09-01525-03-019500-403-5B490500403525-04-020500-403-6B490500403625-04-021

What the firm is doing

On 09/26/2025, the firm emailed a notice to an affected customer informing them that due to identified testing issues, the firm was requesting return of gluteal implants. On 11/17/2025, the firm send an "URGENT Medical Device removal of AART Silicone Implants" Letter to customer informing them that Alpha Aesthetics is voluntarily removing products as they conduct an analysis to determine the regulatory status of the devices. Customers are instructed to: 1. Either return the affected products that have not been implanted to Alpha Aesthetics at the company's expense, or discard affected products. 2. Acknowledge their actions via the enclosed "Medical Device Return Response" letter/form. For questions or further assistance with this removal, contact ** or email **.

DistributionShow details

U.S.: AR, AZ, CA, CO, CT, DC, FL, GA, KY, IL, MA, MD, MI, MN, MS, NE, NJ, NY, OH, OK, PA, PR, TX, UT, VA, WA, and WI O.U.S.: N/A

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls